FRONTIENT
Film-coated tablet, 400mg
RxActive license
Active substance (INN)
pazopanib
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength400mg
PackagingUkupno 60 film tableta u bočici plastičnoj u kartonskoj kutiji
ManufacturerPharmacare Premium Ltd., Malta
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU, PROMET I USLUGE "PONTERA PHARMA SOLUTIONS" DOO PODGORICA
Authorization dateApril 11, 2025
Analogs in Montenegro
16Other medicines with the same active substance
FRONTIENTRx
Film-coated tablet, 200mgLIBURADONERx
Film-coated tablet, 200mgLIBURADONERx
Film-coated tablet, 400mgPARIZOLRx
Film-coated tablet, 400mgPARIZOLRx
Film-coated tablet, 200 mgPAZOPANIB HFRx
Film-coated tablet, 200mgPAZOPANIB HFRx
Film-coated tablet, 200mgPAZOPANIB HFRx
Film-coated tablet, 400mgPAZOPANIB SKRx
Film-coated tablet, 400mgPAZOPANIB SKRx
Film-coated tablet, 200mgPAZOPANIB TEVARestricted
Film-coated tablet, 200mgPAZOPANIB TEVARestricted
Film-coated tablet, 400mgPAZOPANIB ZENTIVARx
Film-coated tablet, 200mgPAZOPANIB ZENTIVARx
Film-coated tablet, 400mgVOTRIENTRx
Film-coated tablet, 400mgVOTRIENTRx
Film-coated tablet, 200mgSource: CInMED register